News & Updates

Flu shots reduce spread of infection within households

29 Nov 2024

Influenza vaccination appears to mitigate the risk of secondary infections among unvaccinated household contacts, according to a study.

Flu shots reduce spread of infection within households

29 Nov 2024

Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

29 Nov 2024

Film-coated tablet 400 mg and Solution for IV infusion 400 mg/250 mL

Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

29 Nov 2024

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

29 Nov 2024

Professor Jean-Jacques Kiladjian, Professor of Clinical Pharmacology, Consultant Haematologist, and head of the Clinical Investigation Centre of Hôpital Saint-Louis & Université Paris Cité in Paris, France, discusses the drawbacks of conventional therapy for PV, and how ropeginterferon alfa-2b may support a shift in treatment.

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

29 Nov 2024

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

29 Nov 2024

MIMS Oncology explores the current landscape of polycythaemia vera management in Singapore and the role of the newly launched ropeginterferon alfa-2b in improving patient outcomes. During an interview, Dr Dawn Mya, a leading haematologist practicing at Parkway Cancer Centre, Singapore, provides expert insights into the therapeutic potential of this novel treatment.

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

29 Nov 2024

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD

28 Nov 2024

Individuals with worsening chronic kidney disease (CKD) are at greater risk for emergently treated hypocalcemia with denosumab, and the highest risk is observed among dialysis-dependent (DD) patients and those with CKD–mineral and bone disorder (CKD-MBD), reveals a study.

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD

28 Nov 2024

Long-term benefits of medications for schizophrenia called into question

28 Nov 2024

Antipsychotics, antidepressants, and benzodiazepines do not appear to have a protective association with all-cause mortality in patients with schizophrenia when controlling for immortal time bias (ITB), suggesting that the effects of these drugs on mortality may be overestimated in analyses not adjusting for ITB, according to a study.

Long-term benefits of medications for schizophrenia called into question

28 Nov 2024

Tranexamic acid as good as norethisterone for HMB treatment

28 Nov 2024 by

Tranexamic acid was as effective as norethisterone in reducing menstrual blood loss and the duration of menstrual period in women with heavy menstrual bleeding (HMB), according to a study presented at RCOG 2024.

Tranexamic acid as good as norethisterone for HMB treatment

28 Nov 2024

Drugs vs surgery for weight loss: The better of 2 options

28 Nov 2024 by

In a first-of-a-kind meta-analysis comparing the efficacy and safety of different treatment options for obesity, weight loss surgery using the Roux-en-Y gastric bypass (RYGB) yields optimal weight loss than other surgical procedures or weight loss medications.

Drugs vs surgery for weight loss: The better of 2 options

28 Nov 2024

Inhaled analgesic provides adequate pain relief for minor gynae procedures

27 Nov 2024 by

Data presented at RCOG 2024 reflect the suitability of methoxyflurane – a short-acting analgesic delivered via a handheld, self-administered inhaler device – for use in the performance of minor gynaecology procedures.

Inhaled analgesic provides adequate pain relief for minor gynae procedures

27 Nov 2024

Add-on intrauterine misoprostol lowers PPH risk during caesarean delivery

27 Nov 2024 by

Adding intrauterine misoprostol to oxytocin significantly reduced the incidence of postpartum haemorrhage (PPH) in women who underwent caesarean section (CS) compared with oxytocin alone, according to a study presented at RCOG 2024.

Add-on intrauterine misoprostol lowers PPH risk during caesarean delivery

27 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Flu shots reduce spread of infection within households

Flu shots reduce spread of infection within households

Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD

Long-term benefits of medications for schizophrenia called into question

Long-term benefits of medications for schizophrenia called into question

Tranexamic acid as good as norethisterone for HMB treatment

Tranexamic acid as good as norethisterone for HMB treatment

Drugs vs surgery for weight loss: The better of 2 options

Drugs vs surgery for weight loss: The better of 2 options

Inhaled analgesic provides adequate pain relief for minor gynae procedures

Inhaled analgesic provides adequate pain relief for minor gynae procedures

Add-on intrauterine misoprostol lowers PPH risk during caesarean delivery

Add-on intrauterine misoprostol lowers PPH risk during caesarean delivery